breast cancer. Eli Lilly

Latecomer Verzenio stands out from Ibrance, Kisqali in launch's early days: Lilly
Fierce Pharma
Mon, 10/30/17 - 10:00 am
Verzenio
Ibrance
Kisqali
drug launches
breast cancer. Eli Lilly
Pfizer
Novartis